3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：344
1[1]Goran K,Hansson.Immune mechanism in atherosclerosis arteroscler thromb.Vasc Biol,2001,21:1876-1890.
2[2]Mach F,Schonbeck U,Binnefoy JY,et al.Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40:induction of collagenase,stromelysin,and tissue factor.Circulation,1997,96:396-399.
3[3]Koerig W.Inflammation and coronary heart disease:an overview.Cardiol Rev,2001,9:31-35.
4[4]Ferm D,Parrotto S,Bnili S,et al.Simvastatin inhibite the monocyte expresation of proinflammalory cytokines in patiente with hypercholesterolemia.J Am Coll Cardiol,2000,36:427-431.
5[5]Crisby M,Nordin-Fredriksson G,Shch PK,et al.Pravastatio treatment increaacs,and decreascs lipid content,inflammation,metalloproteiaacs,and cell death in human carotid plaques:implication for plaque stabilisation.Circulation,2001,103:926-933.
6[6]Kai H,Ikeda H,Yasukawa H,et al.Perpherial blood levels of matrix metalloproteinase-2 and 9 are in patients with acute coronary sndrome.J Am Coll Cardiol,1998,32:368-372.
7LIBBY P,RIDKER PM,MASERI A.Inflammation and atherosclerosis[J].Circulation,2002,105 (9):1135-1143.
8LI YY,MCTIERNAN CF,FELDMAN AM.Interplay of matrix metalloproteinase;tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling[J].Cardiovase Res,2000,46(2):214-224.
9NISSEN SE.High-dose statins in acute coronary syndromes.not just lipid levels[J].JAMA,2004,292(11):1307-1316.
10RICLKER PM.High-sensitivity C-reactive protein; potential adjunct for global risk assessmention in the primary prerention of cardiovascular disease[J].Circulation,2001,103(5):1813-1818.
